Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/05 → 10/31/09 |
Funding
- Eli Lilly and Company: $39,133.00
A Phase One Trail of Gemcitavine and Paclitaxel (GEMTAX) Plus Low Dose Radiation in Patients with Recurrent Head and Neck Cancer
- Arnold, Susanne M (PI)